Abstract:Highlight • The effective integration of machine learning and genetic algorithms to optimize peptide modifications offers a promising avenue for peptide design. • It introduces novel techniques for the directly modification of small peptides, particularly in cases where insufficient data is available for traditional approaches. • It strategically positions the introduction of positive charge amino acids via our model instead of a mere cumulative addition of positive charged amino-acids. • Minimal modifications to the peptide structure can exert a profound influence on the inhibitory activity of LPS-binding peptides. Introduction Antimicrobial peptides (AMPs) are valuable alternatives to traditional antibiotics, possess a variety of potent biological activities and exhibit immunomodulatory effects that alleviate difficult-to-treat infections. Clarifying the structure-activity relationships of AMPs can direct the synthesis of desirable peptide therapeutics. Objectives In this study, the lipopolysaccharide-binding domain (LBD) was identified through machine learning-guided directed evolution, which acts as a functional domain of the anti-lipopolysaccharide factor family of AMPs identified from Marsupenaeus japonicus . Methods LBD A-D was identified as an output of this algorithm, in which the original LBD Mj sequence was the input, and the three-dimensional solution structure of LBD B was determined using nuclear magnetic resonance. Furthermore, our study involved a comprehensive series of experiments, including morphological studies and in vitro and in vivo antibacterial tests. Results The NMR solution structure showed that LBD B possesses a circular extended structure with a disulfide crosslink at the terminus and two 3 10 -helices and exhibits a broad antimicrobial spectrum. In addition, scanning electron microscopy (SEM) and transmission electron microscopy (TEM) showed that LBD B induced the formation of a cluster of bacteria wrapped in a flexible coating that ruptured and consequently killed the bacteria. Finally, coinjection of LBD B , Vibrio alginolyticus and Staphylococcus aureus in vivo improved the survival of M. japonicus , demonstrating the promising therapeutic role of LBD B for treating infectious disease. Conclusions The findings of this study pave the way for the rational drug design of activity-enhanced peptide antibiotics. Graphical abstract Download : Download high-res image (110KB) Download : Download full-size image Employing machine learning and genetic algorithms, we developed structurally enhanced antimicrobial peptides boasting exceptional efficacy.

Synthetic molecular evolution of antimicrobial peptides

Using chemical synthesis to optimise antimicrobial peptides in the fight against antimicrobial resistance

Advances in Artificially Designed Antibacterial Active Antimicrobial Peptides.

Computational Methods and Tools in Antimicrobial Peptide Research

Combining genetic algorithm with machine learning strategies for designing potent antimicrobial peptides

Machine learning and genetic algorithm-guided directed evolution for the development of antimicrobial peptides

Computational resources and tools for antimicrobial peptides

Chemically modified and conjugated antimicrobial peptides against superbugs.

Advances in microbial antimicrobial peptides expression system and transformation strategy

Towards the Development of Synthetic Antibiotics: Designs Inspired by Natural Antimicrobial Peptides

Integrated computational approaches for advancing antimicrobial peptide development

Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms

A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides

Design methods for antimicrobial peptides with improved performance

Antimicrobial Peptides: Design, Chemical Synthesis, Activity Evaluation, and Application

A generative artificial intelligence approach for antibiotic optimization

De novo synthetic antimicrobial peptide design with a recurrent neural network

Chemical modifications to increase the therapeutic potential of antimicrobial peptides

Current synthetic chemistry towards cyclic antimicrobial peptides

Current Status of Molecular Design of Cationic Antimicrobial Peptides

Engineering Antimicrobial Peptides with Improved Antimicrobial and Hemolytic Activities